SLONIN JONATHAN Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$365,346.61

Insider Activity of SLONIN JONATHAN

According to the SEC Form 4 filings, SLONIN JONATHAN, being in a position of

  1. Chief Medical Officer at Pacira BioSciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10261 share for $240,432,
    over all time since 2022-07-05, has bought 0 shares, and sold 22126 shares for $605,778.

Biography of SLONIN JONATHAN

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $240,4323100

Comparison of Insiders on Amount of Buys and Sells

2026-08-17SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
3,040
0.0077%
$23.23$70,619+11.14%
2026-03-17SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
3,261
0.0079%
$22.82$74,416+13.15%
2025-11-17SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
3,960
0.0088%
$24.09$95,396+2.01%
2025-01-06SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
879
0.0019%
$18.40$16,174+32.23%
2024-08-02SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
945
0.0019%
$20.05$18,947+5.17%
2024-07-02SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
2,836
0.0062%
$28.25$80,117-6.79%
2024-06-11SalePacira BioSciences, Inc.
PCRX
Chief Medical Officer
5,012
0.0106%
$28.57$143,193-26.84%
2023-06-07SalePacira BioSciences, Inc.
PCRX
Chief Clinical Officer
490
0.0011%
$37.87$18,554-18.42%
2023-06-06SalePacira BioSciences, Inc.
PCRX
Chief Clinical Officer
471
0.001%
$38.99$18,365-21.55%
2022-08-03SalePacira BioSciences, Inc.
PCRX
Chief Clinical Officer
308
0.0006%
$55.70$17,156-27.73%
2022-07-05SalePacira BioSciences, Inc.
PCRX
Chief Clinical Officer
924
0.002%
$57.19$52,842-26.07%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.